Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization

PHASE4RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 12, 2023

Primary Completion Date

January 1, 2025

Study Completion Date

February 1, 2025

Conditions
Ischemic Stroke
Interventions
DRUG

Colchicine

Oral colchicine will be initiated with a dose of 0.5 mg per day during 14 days. Acetylsalicylic acid was used as an antiplatelet agent (300 mg on days 1 and continuing with 100 mg/day).

DRUG

Clopidogrel

Dual antiplatelet therapy includes ASA (300 mg on days 1 and continuing with 100 mg/day) and clopidogrel (300 mg on days 1 and continuing with 75 mg/day).

Trial Locations (2)

354057

RECRUITING

Sochi City Hospital #4, Sochi

650002

RECRUITING

Research Institute for Complex Issues of Cardiovascular Diseas, Kemerovo

All Listed Sponsors
lead

Mikhail Zykov

OTHER